• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Nxstage Medical, Inc. (NXTM)

    -NasdaqGS
    18.27 0.24(1.33%) Dec 18, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.9
    Mean Recommendation (last week):1.9
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:20.00
    Median Target:20.50
    High Target:24.00
    Low Target:14.00
    No. of Brokers:6

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Dec 4, 2012Northland SecuritiesDowngradeOutperformMarket Perform
    Sep 7, 2012Northland SecuritiesInitiated Outperform
    Feb 28, 2012Feltl & Co.DowngradeBuyHold
    Dec 3, 2010JefferiesInitiated Buy
    Oct 14, 2010Rodman & RenshawDowngradeMkt PerformMkt Underperform
    Sep 15, 2010Feltl & Co.Initiated Buy
    Jul 26, 2010Rodman & RenshawDowngradeMkt OutperformMkt Perform
    Jan 8, 2010Rodman & RenshawInitiated Mkt Outperform
    Jun 5, 2009William BlairUpgradeMkt PerformOutperform
    Jul 29, 2008SMH CapitalInitiated Buy

    More Upgrades & Downgrades for NXTM

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0555
    Buy0111
    Hold0111
    Underperform0000
    Sell0111

    Data provided by Thomson/First Call


    Currency in USD.